Literature DB >> 22120873

Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.

Concetta Crisafulli1, Alberto Chiesa, Changsu Han, Soo-Jung Lee, Moon Ho Park, Beatrice Balzarro, Costanza Andrisano, Ashwin A Patkar, Chi-Un Pae, Alessandro Serretti.   

Abstract

The aim of this study is to investigate possible associations between a set of single-nucleotide polymorphisms (SNPs) within 10 genes with Schizophrenia (SCZ) and response to antipsychotics in Korean in-patients treated with antipsychotics. Two hundred and twenty-one SCZ in-patients and 170 psychiatrically healthy controls were genotyped for 42 SNPs within ABCB1, ABCB4, TAP2, CLOCK, CPLX1, CPLX2, SYN2, NRG1, 5HTR1A and GPRIN2. Baseline and final clinical measures, including the Positive and Negative Symptoms Scale (PANSS), were recorded. Rs10042486 within 5HTR1A was associated with both SCZ and clinical improvement on PANSS total scores as well as on PANSS positive and PANSS negative scores. The haplotype analyses focusing on the four, three and two blocks' haplotypes within 5HTR1A confirmed such findings as well. We did not observe any significant association between the remaining genetic variants under investigation in this study and clinical outcomes. Our preliminary findings suggest that rs10042486 within 5HTR1A promoter region could be associated with SCZ and with clinical improvement on PANSS total, positive and negative scores in Korean patients with SCZ. However, taking into account the several limitations of our study, further research is needed to draw more definitive conclusions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120873     DOI: 10.1007/s00406-011-0278-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  Schizophrenia.

Authors:  Robert Freedman
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

Review 3.  Environmental risk factors for psychopathology.

Authors:  Karin Schlossberg; Anda Massler; Gil Zalsman
Journal:  Isr J Psychiatry Relat Sci       Date:  2010       Impact factor: 0.481

4.  Spurious genetic associations.

Authors:  Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-03-08       Impact factor: 13.382

5.  The association of CLOCK gene T3111C polymorphism and hPER3 gene 54-nucleotide repeat polymorphism with Chinese Han people schizophrenics.

Authors:  Jing Zhang; Ga Liao; Chang Liu; Lei Sun; Yanyou Liu; Yuhui Wang; Zhou Jiang; Zhengrong Wang
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

Review 6.  Circadian rhythms and clock genes in psychotic disorders.

Authors:  Elaine Waddington Lamont; Daniel L Coutu; Nicolas Cermakian; Diane B Boivin
Journal:  Isr J Psychiatry Relat Sci       Date:  2010       Impact factor: 0.481

7.  Positive association between synapsin II and schizophrenia.

Authors:  Qi Chen; Guang He; Xiao Yan Wang; Qing Ying Chen; Xin Min Liu; Zhong Zhong Gu; Jie Liu; Ke Qing Li; Shi Ji Wang; Shao Ming Zhu; Guo Ying Feng; Lin He
Journal:  Biol Psychiatry       Date:  2004-08-01       Impact factor: 13.382

8.  Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.

Authors:  Masaki Kato; Tsuyoshi Fukuda; Masataka Wakeno; Gaku Okugawa; Yoshiteru Takekita; Syunsuke Watanabe; Megumi Yamashita; Yuka Hosoi; Junichi Azuma; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-01-05       Impact factor: 3.568

9.  Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia.

Authors:  Rainald Mössner; Anna Schuhmacher; Kai-Uwe Kühn; Gabriela Cvetanovska; Dan Rujescu; Peter Zill; Boris B Quednow; Marcella Rietschel; Wolfgang Wölwer; Wolfgang Gaebel; Michael Wagner; Wolfgang Maier
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

10.  Newer molecules in the treatment of schizophrenia: A clinical update.

Authors:  Abhishek Ghosh; Kaustav Chakraborty; Surendra Kumar Mattoo
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

View more
  7 in total

1.  No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia.

Authors:  Sarah Tosato; Martina Zanoni; Chiara Bonetto; Federica Tozzi; Clyde Francks; Elisa Ira; Simona Tomassi; Mariaelena Bertani; Dan Rujescu; Ina Giegling; David St Clair; Michele Tansella; Mirella Ruggeri; Pierandrea Muglia
Journal:  Neuromolecular Med       Date:  2014-08-21       Impact factor: 3.843

2.  Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.

Authors:  Ina Giegling; Beatrice Balzarro; Stefano Porcelli; Martin Schäfer; Annette M Hartmann; Marion Friedl; Bettina Konte; Philipp Krämer; Hans-Jürgen Möller; Diana De Ronchi; Hans H Stassen; Alessandro Serretti; Dan Rujescu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-15       Impact factor: 5.270

3.  Schizophrenia shows a unique metabolomics signature in plasma.

Authors:  Y He; Z Yu; I Giegling; L Xie; A M Hartmann; C Prehn; J Adamski; R Kahn; Y Li; T Illig; R Wang-Sattler; D Rujescu
Journal:  Transl Psychiatry       Date:  2012-08-14       Impact factor: 6.222

4.  The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia.

Authors:  Stefano Porcelli; Chi-Un Pae; Changsu Han; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Beatrice Balzarro; Siegfried Alberti; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

Review 5.  Pharmacogenomic Characterization in Bipolar Spectrum Disorders.

Authors:  Stefano Fortinguerra; Vincenzo Sorrenti; Pietro Giusti; Morena Zusso; Alessandro Buriani
Journal:  Pharmaceutics       Date:  2019-12-21       Impact factor: 6.321

Review 6.  HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Yosuke Koshikawa; Aran Tajika; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-29       Impact factor: 5.176

7.  5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients.

Authors:  Zai-Quan Dong; Xi-Rong Li; Lin He; Guang He; Tao Yu; Xue-Li Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-04       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.